Gamida Cell Ltd.

Gamida Cell Ltd.

Gamida Cell Ltd.

Overview
Date Founded

1998

Headquarters

Ofer Building,5 Nahum Hafzadi Street,Jerusalem 91340

Type of Company

Private

Industries

Pharmaceuticals
Medical Products & Equipment
Holding Companies

Company Description

Gamida Cell Ltd. engages in the clinical development of hematopoietic stem cell therapeutics. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.

Executives & Employees

Co-Founder

Chief Executive Officer

President

Chief Financial Officer

Chief Medical Officer

Vice President, Clinical Development & Regulatory Affairs

Vice President-Quality Assurance

Board of Directors

Chief Executive Officer at Gamida Cell Ltd.

Governor of the Minerva Academy at Minerva Project, Inc.

Chief Executive Officer & Non-Executive Director at Avita Medical Ltd.

Chief Executive Officer at Clal Biotechnology Industries Ltd.

President & Chief Executive Officer at Cognition Therapeutics, Inc.

Managing Partner at I.H.C.V Israel Healthcare Ventures Ltd.

Co-Founder at Bio Control Medical BCM Ltd.

President at Gamida Cell Ltd.

Co-Founder at Bio Control Medical BCM Ltd.

Director at Gamida Cell Ltd.

Paths to Gamida Cell Ltd.
Potential Connections via
Relationship Science
You
Gamida Cell Ltd.
Recent Transactions
Details Hidden

Clal Biotechnology Industries Ltd. purchases Gamida Cell Ltd. from Teva Pharmaceutical Industries Ltd.

Details Hidden

Novartis AG, Novartis Pharma AG purchase Gamida Cell Ltd. from Elbit Imaging Ltd.

Investors
Details Hidden

Novartis AG develops, manufactures, and markets healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Details Hidden
Details Hidden